Literature DB >> 15734833

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.

Kitt Falk Petersen1, Sylvie Dufour, Douglas Befroy, Michael Lehrke, Rosa E Hendler, Gerald I Shulman.   

Abstract

To examine the mechanism by which moderate weight reduction improves basal and insulin-stimulated rates of glucose metabolism in patients with type 2 diabetes, we used (1)H magnetic resonance spectroscopy to assess intrahepatic lipid (IHL) and intramyocellular lipid (IMCL) content in conjunction with hyperinsulinemic-euglycemic clamps using [6,6-(2)H(2)]glucose to assess rates of glucose production and insulin-stimulated peripheral glucose uptake. Eight obese patients with type 2 diabetes were studied before and after weight stabilization on a moderately hypocaloric very-low-fat diet (3%). The diabetic patients were markedly insulin resistant in both liver and muscle compared with the lean control subjects. These changes were associated with marked increases in IHL (12.2 +/- 3.4 vs. 0.6 +/- 0.1%; P = 0.02) and IMCL (2.0 +/- 0.3 vs. 1.2 +/- 0.1%; P = 0.02) compared with the control subjects. A weight loss of only approximately 8 kg resulted in normalization of fasting plasma glucose concentrations (8.8 +/- 0.5 vs. 6.4 +/- 0.3 mmol/l; P < 0.0005), rates of basal glucose production (193 +/- 7 vs. 153 +/- 10 mg/min; P < 0.0005), and the percentage suppression of hepatic glucose production during the clamp (29 +/- 22 vs. 99 +/- 3%; P = 0.003). These improvements in basal and insulin-stimulated hepatic glucose metabolism were associated with an 81 +/- 4% reduction in IHL (P = 0.0009) but no significant change in insulin-stimulated peripheral glucose uptake or IMCL (2.0 +/- 0.3 vs. 1.9 +/- 0.3%; P = 0.21). In conclusion, these data support the hypothesis that moderate weight loss normalizes fasting hyperglycemia in patients with poorly controlled type 2 diabetes by mobilizing a relatively small pool of IHL, which reverses hepatic insulin resistance and normalizes rates of basal glucose production, independent of any changes in insulin-stimulated peripheral glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734833      PMCID: PMC2995496          DOI: 10.2337/diabetes.54.3.603

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  34 in total

1.  Mechanism of insulin resistance in A-ZIP/F-1 fatless mice.

Authors:  J K Kim; O Gavrilova; Y Chen; M L Reitman; G I Shulman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 2.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

3.  The hormone resistin links obesity to diabetes.

Authors:  C M Steppan; S T Bailey; S Bhat; E J Brown; R R Banerjee; C M Wright; H R Patel; R S Ahima; M A Lazar
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

4.  Lipid-dependent control of hepatic glycogen stores in healthy humans.

Authors:  H Stingl; M Krssák; M Krebs; M G Bischof; P Nowotny; C Fürnsinn; G I Shulman; W Waldhäusl; M Roden
Journal:  Diabetologia       Date:  2001-01       Impact factor: 10.122

5.  Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.

Authors:  M Roden; H Stingl; V Chandramouli; W C Schumann; A Hofer; B R Landau; P Nowotny; W Waldhäusl; G I Shulman
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

6.  Mechanism of troglitazone action in type 2 diabetes.

Authors:  K F Petersen; M Krssak; S Inzucchi; G W Cline; S Dufour; G I Shulman
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

7.  Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.

Authors:  J K Kim; J J Fillmore; Y Chen; C Yu; I K Moore; M Pypaert; E P Lutz; Y Kako; W Velez-Carrasco; I J Goldberg; J L Breslow; G I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

8.  Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.

Authors:  A Gastaldelli; S Baldi; M Pettiti; E Toschi; S Camastra; A Natali; B R Landau; E Ferrannini
Journal:  Diabetes       Date:  2000-08       Impact factor: 9.461

9.  Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

Authors:  I Shimomura; R E Hammer; S Ikemoto; M S Brown; J L Goldstein
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

10.  Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes.

Authors:  G Boden; X Chen; E Capulong; M Mozzoli
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

View more
  300 in total

1.  Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance.

Authors:  François R Jornayvaz; Hui-Young Lee; Michael J Jurczak; Tiago C Alves; Fitsum Guebre-Egziabher; Blas A Guigni; Dongyan Zhang; Varman T Samuel; J Enrique Silva; Gerald I Shulman
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

2.  Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.

Authors:  Naoki Kumashiro; Derek M Erion; Dongyan Zhang; Mario Kahn; Sara A Beddow; Xin Chu; Christopher D Still; Glenn S Gerhard; Xianlin Han; James Dziura; Kitt Falk Petersen; Varman T Samuel; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

3.  Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Seyed Rafie Arefhosseini; Mehrangiz Ebrahimi-Mameghani; Alireza Farsad Naeimi; Manoochehr Khoshbaten; Javad Rashid
Journal:  Health Promot Perspect       Date:  2011-12-20

4.  Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.

Authors:  Kitt Falk Petersen; Sylvie Dufour; Jing Feng; Douglas Befroy; James Dziura; Chiara Dalla Man; Claudio Cobelli; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

Review 5.  Development of type 2 diabetes in children and adolescents.

Authors:  Ram Weiss; Sara E Taksali; Sonia Caprio
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 6.  Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.

Authors:  Katsutaro Morino; Kitt Falk Petersen; Gerald I Shulman
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

Review 7.  Signalling mechanisms linking hepatic glucose and lipid metabolism.

Authors:  M O Weickert; A F H Pfeiffer
Journal:  Diabetologia       Date:  2006-05-23       Impact factor: 10.122

8.  Type 2 diabetes, bariatric surgery and the risk of subsequent gestational diabetes.

Authors:  S Steven; S Woodcock; P K Small; R Taylor
Journal:  Obstet Med       Date:  2011-09-15

9.  Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance.

Authors:  Cheol Soo Choi; Jonathan J Fillmore; Jason K Kim; Zhen-Xiang Liu; Sheene Kim; Emily F Collier; Ameya Kulkarni; Alberto Distefano; Yu-Jin Hwang; Mario Kahn; Yan Chen; Chunli Yu; Irene K Moore; Richard M Reznick; Takamasa Higashimori; Gerald I Shulman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 10.  Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.

Authors:  Ludovico Abenavoli; Natasa Milic; Valentina Peta; Francesco Alfieri; Antonino De Lorenzo; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.